Zhou JY, Chen L, Zhang B, et al. Quality Assessments of Long-Term Quantitative Proteomic Analysis of Breast Cancer Xenograft Tissues. J Proteome Res. 2017;16(12):4523-4530. doi:10.1021/acs.jproteome.7b00362
Publications
Bray MA, Gustafsdottir SM, Rohban MH, et al. A dataset of images and morphological profiles of 30 000 small-molecule treatments using the Cell Painting assay. Gigascience. 2017;6(12):1-5. doi:10.1093/gigascience/giw014
Schmid-Burgk JL. Disruptive non-disruptive applications of CRISPR/Cas9. Curr Opin Biotechnol. 2017;48:203-209. doi:10.1016/j.copbio.2017.06.001
Yu L, Lutz MW, Farfel JM, et al. Neuropathologic features of TOMM40 ’523 variant on late-life cognitive decline. Alzheimers Dement. 2017;13(12):1380-1388. doi:10.1016/j.jalz.2017.05.002
Chouraki V, Preis SR, Yang Q, et al. Association of amine biomarkers with incident dementia and Alzheimer’s disease in the Framingham Study. Alzheimers Dement. 2017;13(12):1327-1336. doi:10.1016/j.jalz.2017.04.009
Lenihan JA, Saha O, Heimer-McGinn V, Cryan JF, Feng G, Young PW. Decreased Anxiety-Related Behaviour but Apparently Unperturbed NUMB Function in Ligand of NUMB Protein-X (LNX) 1/2 Double Knockout Mice. Mol Neurobiol. 2017;54(10):8090-8109. doi:10.1007/s12035-016-0261-0
Meyers RM, Bryan JG, McFarland JM, et al. Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells. Nat Genet. 2017;49(12):1779-1784. doi:10.1038/ng.3984
Ivey KL, Rimm EB, Kraft P, et al. Identifying the metabolomic fingerprint of high and low flavonoid consumers. Journal of nutritional science. 2017;6:e34. doi:10.1017/jns.2017.27
Cremaschi L, Kardell M, Johansson V, et al. Prevalences of autoimmune diseases in schizophrenia, bipolar I and II disorder, and controls. Psychiatry Res. 2017;258:9-14. doi:10.1016/j.psychres.2017.09.071
Filho JWG, Islam MT, Ali ES, et al. A comprehensive review on biological properties of citrinin. Food Chem Toxicol. 2017;110:130-141. doi:10.1016/j.fct.2017.10.002